Simple blood test could spot pancreatic cancer early
NCT ID NCT07528430
First seen Apr 23, 2026 · Last updated Jun 15, 2026 · Updated 12 times
Summary
This study aims to develop and validate a blood test that detects DNA changes (epigenetic signatures) to diagnose pancreatic cancer. Researchers will collect blood samples from 450 adults with or at high risk for pancreatic cancer and follow them for up to 5 years. The goal is to create a non-invasive tool for earlier and more accurate diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER, ADVANCED OR METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland Baltimore Washington Medical Center
Glen Burnie, Maryland, 21061, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.